340B COMES UP DURING SENATE HEARING

340B COMES UP DURING SENATE HEARING Created by j.blackburn@americanhealthcare.com on 3/22/2016 5:16:09 PM

As we reported in the Drug Discount Monitor, the chairwoman of the Senate Special Committee on Aging grilled a Turing Pharmaceuticals executive during a March 17 hearing for instructing a subordinate to dispute 340B claims in order to boost company profits. Click here and here for video clips of Chairwoman Susan Collins' (R-Maine) strong defense of 340B. We thank Senator Collins for her leadership on the important issue of high drug prices